Your browser doesn't support javascript.
loading
Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?
Baboudjian, Michael; Roumiguié, Mathieu; Peltier, Alexandre; Oderda, Marco; Barret, Eric; Fromont, Gaëlle; Dariane, Charles; Fiard, Gaelle; Charvet, Anne-Laure; Gondran-Tellier, Bastien; Durand-Labrunie, Camille; Campello, Pierre Vincent; Roumeguère, Thierry; Diamand, Romain; Diana, Pietro; Touzani, Alae; Beauval, Jean-Baptiste; Daniel, Laurent; Rouprêt, Morgan; Ruffion, Alain; Ploussard, Guillaume.
Afiliación
  • Baboudjian M; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain. Michael.BABOUDJIAN@outlook.fr.
  • Roumiguié M; Department of Urology, La Conception Hospital, Aix-Marseille University, APHM, Marseille, France. Michael.BABOUDJIAN@outlook.fr.
  • Peltier A; Department of Urology, North Hospital, Aix-Marseille University, APHM, Marseille, France. Michael.BABOUDJIAN@outlook.fr.
  • Oderda M; Department of Urology, Toulouse University Hospital, Toulouse, France.
  • Barret E; Department of Urology, Hôpital Universitaire de Bruxelles, Jules Bordet Institute and Erasme Hopsital, Université Libre de Bruxelles, Brussels, Belgium.
  • Fromont G; Division of Urology, Department of Surgical Sciences-Urology, Città Della Salute e della Scienza di Torino-Molinette Hospital, University of Turin, Turin, Italy.
  • Dariane C; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Fiard G; Department of Pathology, CHRU Tours, Tours, France.
  • Charvet AL; Department of Urology, Hôpital Européen Georges-Pompidou, APHP, ParisParis University-U1151 Inserm-INEM, Necker, Paris, France.
  • Gondran-Tellier B; Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC, Grenoble, France.
  • Durand-Labrunie C; Department of Urology, North Hospital, Aix-Marseille University, APHM, Marseille, France.
  • Campello PV; Department of Urology, La Conception Hospital, Aix-Marseille University, APHM, Marseille, France.
  • Roumeguère T; Department of Urology, Toulouse University Hospital, Toulouse, France.
  • Diamand R; Service d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon,, Lyon, France.
  • Diana P; Department of Urology, Hôpital Universitaire de Bruxelles, Jules Bordet Institute and Erasme Hopsital, Université Libre de Bruxelles, Brussels, Belgium.
  • Touzani A; Department of Urology, Hôpital Universitaire de Bruxelles, Jules Bordet Institute and Erasme Hopsital, Université Libre de Bruxelles, Brussels, Belgium.
  • Beauval JB; Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.
  • Daniel L; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.
  • Rouprêt M; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.
  • Ruffion A; Department of Pathology, La Conception Hospital, Aix-Marseille University, APHM, Marseille, France.
  • Ploussard G; Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, 75013, Paris, France.
World J Urol ; 40(10): 2423-2429, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35980449
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: World J Urol Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: World J Urol Año: 2022 Tipo del documento: Article País de afiliación: España